Loading…
HuidaGene is a biotechnology company developing gene therapies for ophthalmology, neurology, and neuromuscular diseases. Its pipeline includes treatments for conditions such as RPE65-associated inherited retinal dystrophies, Huntington's disease, and Duchenne muscular dystrophy.
AI named HuidaGene in February 2026.
